Processa Pharmaceuticals (PCSA) Asset Utilization Ratio (2013 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Asset Utilization Ratio came in at 0.26 in Q4 2016, down 10.91% YoY from 0.29 in Q1 2016, and down 54.52% on a QoQ basis from 0.57 in Q3 2016.
Processa Pharmaceuticals (PCSA) Asset Utilization Ratio (2013 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 4 years of Asset Utilization Ratio data on file, last reported at 0.26 in Q4 2016.
- Quarterly Asset Utilization Ratio fell 10.91% year-over-year to 0.26 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was 0.26 (down 10.91% YoY) and the FY2016 annual result came in at 0.09, up 8.62% from the prior year.
- Asset Utilization Ratio fell to 0.26 in Q4 2016, from 0.57 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.88 in Q2 2016 to a low of 0.06 in Q4 2014.
- A 4-year average of 0.26 and a median of 0.1 in 2014 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2014 — Asset Utilization Ratio plunged 34.67% — and 2016, when it surged 1160.05%.
- Tracing PCSA's Asset Utilization Ratio over 4 years: stood at 0.09 in 2013, then plunged by 34.67% to 0.06 in 2014, then surged by 384.61% to 0.29 in 2015, then slipped by 10.91% to 0.26 in 2016.
- The last three Asset Utilization Ratio figures came in at 0.26 (Q4 2016), 0.57 (Q3 2016), and 0.88 (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.13 |
| 10 | Processa Pharmaceuticals | 5.72 Mn | 5.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 0.26 |
| Sep 30, 2016 | 0.57 |
| Jun 30, 2016 | 0.88 |
| Mar 31, 2016 | 0.79 |
| Dec 31, 2015 | 0.29 |
| Sep 30, 2015 | 0.12 |
| Jun 30, 2015 | 0.07 |
| Mar 31, 2015 | 0.07 |
| Dec 31, 2014 | 0.06 |
| Sep 30, 2014 | 0.08 |
| Jun 30, 2014 | 0.10 |
| Mar 31, 2014 | 0.10 |
| Dec 31, 2013 | 0.09 |
| Sep 30, 2013 | 0.07 |